Company Filing History:
Years Active: 2017
Title: Innovations of Inventor Sy Lee in Inhalable Powder Formulations
Introduction
Sy Lee is an innovative inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalable powder formulations. His work focuses on addressing NMDA receptor hypofunction-related diseases, which are critical in various neurological conditions.
Latest Patents
Sy Lee holds a patent for the "Use of inhalable powder formulation comprising growth hormone for preventing or treating NMDA receptor hypofunction-related diseases." This patent describes a method for administering a therapeutically effective amount of an inhalable powder formulation containing growth hormone (GH) to treat or prevent NMDA receptor hypofunction-related diseases. The formulation aims to provide a novel approach to managing these conditions effectively.
Career Highlights
Sy Lee is associated with Medigenebio Corporation, where he continues to work on groundbreaking research and development projects. His expertise in inhalable formulations has positioned him as a key player in the pharmaceutical industry.
Collaborations
Sy Lee collaborates with notable professionals in his field, including his coworker Sung-Ick Park. Their combined efforts contribute to advancing research and innovation in inhalable therapies.
Conclusion
Sy Lee's contributions to inhalable powder formulations represent a significant advancement in treating NMDA receptor hypofunction-related diseases. His innovative approach and dedication to research continue to impact the pharmaceutical landscape positively.